MIF and neoplasm: Recent studies have shown that MIF-CD74 can inhibit anti-tumor immune responses by recruiting tumor-associated macrophages (TAMs) or directly inhibiting T cell activation (Balogh et al. 2018; Klemke et al. 2021).